BRPI1005433A2 - preparações farmacêuticas transdérmicas - Google Patents
preparações farmacêuticas transdérmicasInfo
- Publication number
- BRPI1005433A2 BRPI1005433A2 BRPI1005433A BRPI1005433A BRPI1005433A2 BR PI1005433 A2 BRPI1005433 A2 BR PI1005433A2 BR PI1005433 A BRPI1005433 A BR PI1005433A BR PI1005433 A BRPI1005433 A BR PI1005433A BR PI1005433 A2 BRPI1005433 A2 BR PI1005433A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical preparations
- transdermal pharmaceutical
- transdermal
- preparations
- pharmaceutical
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Obesity (AREA)
- Hematology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0900072A HUP0900072A2 (hu) | 2009-02-06 | 2009-02-06 | Transzdermális gyógyszerkészítmények |
| HU0900072 | 2009-02-06 | ||
| PCT/HU2010/000015 WO2010089617A2 (en) | 2009-02-06 | 2010-02-05 | Transdermal pharmaceutical preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1005433A2 true BRPI1005433A2 (pt) | 2019-09-24 |
Family
ID=89988766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1005433A BRPI1005433A2 (pt) | 2009-02-06 | 2010-02-05 | preparações farmacêuticas transdérmicas |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20120024743A1 (pt) |
| EP (1) | EP2393479A2 (pt) |
| JP (1) | JP2012517414A (pt) |
| KR (1) | KR20110120304A (pt) |
| CN (2) | CN102573793A (pt) |
| AU (1) | AU2010212158A1 (pt) |
| BR (1) | BRPI1005433A2 (pt) |
| CA (1) | CA2751633A1 (pt) |
| CL (1) | CL2011001875A1 (pt) |
| EA (1) | EA023502B1 (pt) |
| HU (1) | HUP0900072A2 (pt) |
| IL (1) | IL214402A0 (pt) |
| MX (1) | MX2011008213A (pt) |
| NZ (1) | NZ594618A (pt) |
| PE (1) | PE20120584A1 (pt) |
| UA (1) | UA107563C2 (pt) |
| WO (1) | WO2010089617A2 (pt) |
| ZA (1) | ZA201105662B (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170065533A1 (en) * | 2011-01-24 | 2017-03-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Nanoparticles for dermal and systemic delivery of drugs |
| US10045935B2 (en) * | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
| US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
| JP5630679B1 (ja) * | 2013-09-08 | 2014-11-26 | 株式会社Ｅ・テック | 揮発性消毒剤、揮発性消毒剤の製造方法 |
| JP2017512757A (ja) * | 2014-02-24 | 2017-05-25 | ウリゲン ファーマシューティカルズ、インコーポレイテッド | 経口投与するためのペントサンポリ硫酸塩の組成物および使用の方法 |
| CN111148749A (zh) | 2016-08-31 | 2020-05-12 | 王子控股株式会社 | 酸性低聚木糖的生产方法和酸性低聚木糖 |
| JP6225321B1 (ja) | 2016-08-31 | 2017-11-08 | 王子ホールディングス株式会社 | ポリ硫酸ペントサンの製造方法 |
| JP6281659B1 (ja) | 2017-02-28 | 2018-02-21 | 王子ホールディングス株式会社 | ポリ硫酸ペントサン、医薬組成物及び抗凝固剤 |
| BR112019025030A2 (pt) * | 2017-05-31 | 2020-06-16 | Oji Holdings Corporation | Preparação umidificante tópica. |
| CA3075485C (en) | 2017-09-12 | 2025-07-08 | Oji Holdings Corporation | PENTOSANE POLYSULFATE AND PROCESS FOR THE PRODUCTION OF PENTOSANE POLYSULFATE |
| MX2020006605A (es) | 2017-12-20 | 2020-09-10 | Oji Holdings Corp | Polisulfato de pentosano y medicamento que contiene polisulfato de pentosano. |
| RU2704623C1 (ru) * | 2018-12-07 | 2019-10-30 | Общество с ограниченной ответственностью "Научно-производственное объединение "Ликом" | Перевязочное средство на биополимерной основе |
| TW202202129A (zh) * | 2020-07-10 | 2022-01-16 | 大陸商江蘇恒瑞醫藥股份有限公司 | 含麻醉藥物活性成分的透皮製劑及其製備方法 |
| CN115475224B (zh) * | 2022-08-31 | 2023-11-28 | 中国人民解放军空军特色医学中心 | 一种用于治疗冻疮的药膏及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1141094B (it) | 1979-12-03 | 1986-10-01 | Gen Electric | Emulsioni di siliconi volantili e acqua e loro metodo di preparazione ed uso |
| DE3010572C2 (de) | 1980-03-19 | 1982-05-06 | Süess, Hans R., Dr., Starrkirch | Hautpflege- und Hautschutzpräparate |
| US4720353A (en) * | 1987-04-14 | 1988-01-19 | Richardson-Vicks Inc. | Stable pharmaceutical w/o emulsion composition |
| US5122519A (en) | 1989-06-27 | 1992-06-16 | American Cyanamid Company | Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
| US5336692A (en) | 1990-06-28 | 1994-08-09 | Medicis Pharmaceutical Corporation | Ointment base and method of use |
| FR2709131B1 (fr) * | 1993-08-18 | 1995-11-10 | Cilag Laboratoire | Dispositif de distribution d'une substance thérapeutique ou cosmétique dont le véhicule inerte est un polydiorganosiloxane volatil, et composition destinée à être utilisée dans le dispositif. |
| DE19837850C1 (de) | 1998-08-20 | 2000-01-05 | Wacker Chemie Gmbh | Mischungen flüchtiger linearer Siloxane, Verfahren zu ihrer Herstellung sowie diese enthaltenden kosmetischen Formulierungen |
| IT1302275B1 (it) | 1998-09-25 | 2000-09-05 | Giorgio Panin | Formulazione di gel idrofobo a base di vitamina e acetato perapplicazione topica. |
| JP4174595B2 (ja) | 2001-11-13 | 2008-11-05 | モーメンテイブ・パーフオーマンス・マテリアルズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | 蒸発可能な担体としてのシロキサンの使用 |
| JP2007511578A (ja) | 2003-11-21 | 2007-05-10 | ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ | ビタミンｄの投与のためのスプレー可能な組成物 |
| GB0506139D0 (en) | 2005-03-24 | 2005-05-04 | Transphase Ltd | A transdermal topical composition and its uses |
| WO2006138035A1 (en) * | 2005-06-13 | 2006-12-28 | Dow Corning Corporation | Vehicle for the delivery of topical lipid soluble pharmaceutical agents |
| WO2007022090A2 (en) * | 2005-08-13 | 2007-02-22 | Collegium Pharmaceutical, Inc. | Topical delivery with a carrier fluid |
| HU227970B1 (en) * | 2007-07-10 | 2012-07-30 | Egis Gyogyszergyar Nyrt | Pharmaceutical compositions containing silicones of high volatility |
-
2009
- 2009-02-06 HU HU0900072A patent/HUP0900072A2/hu not_active Application Discontinuation
-
2010
- 2010-02-05 EP EP10707660A patent/EP2393479A2/en not_active Ceased
- 2010-02-05 KR KR1020117020176A patent/KR20110120304A/ko not_active Ceased
- 2010-02-05 UA UAA201110091A patent/UA107563C2/uk unknown
- 2010-02-05 US US13/148,219 patent/US20120024743A1/en not_active Abandoned
- 2010-02-05 JP JP2011548789A patent/JP2012517414A/ja active Pending
- 2010-02-05 WO PCT/HU2010/000015 patent/WO2010089617A2/en not_active Ceased
- 2010-02-05 EA EA201190134A patent/EA023502B1/ru not_active IP Right Cessation
- 2010-02-05 NZ NZ594618A patent/NZ594618A/en not_active IP Right Cessation
- 2010-02-05 CA CA2751633A patent/CA2751633A1/en not_active Abandoned
- 2010-02-05 CN CN2010800111061A patent/CN102573793A/zh active Pending
- 2010-02-05 BR BRPI1005433A patent/BRPI1005433A2/pt not_active IP Right Cessation
- 2010-02-05 AU AU2010212158A patent/AU2010212158A1/en not_active Abandoned
- 2010-02-05 PE PE2011001443A patent/PE20120584A1/es not_active Application Discontinuation
- 2010-02-05 CN CN2013102181280A patent/CN103349643A/zh active Pending
- 2010-02-05 MX MX2011008213A patent/MX2011008213A/es not_active Application Discontinuation
-
2011
- 2011-08-01 ZA ZA2011/05662A patent/ZA201105662B/en unknown
- 2011-08-02 IL IL214402A patent/IL214402A0/en unknown
- 2011-08-04 CL CL2011001875A patent/CL2011001875A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU0900072D0 (en) | 2009-03-30 |
| IL214402A0 (en) | 2011-09-27 |
| NZ594618A (en) | 2014-01-31 |
| UA107563C2 (uk) | 2015-01-26 |
| AU2010212158A1 (en) | 2011-09-08 |
| CN102573793A (zh) | 2012-07-11 |
| HUP0900072A2 (hu) | 2010-09-28 |
| WO2010089617A2 (en) | 2010-08-12 |
| EA201190134A1 (ru) | 2012-02-28 |
| JP2012517414A (ja) | 2012-08-02 |
| WO2010089617A3 (en) | 2011-06-16 |
| EP2393479A2 (en) | 2011-12-14 |
| MX2011008213A (es) | 2011-09-28 |
| PE20120584A1 (es) | 2012-05-23 |
| US20120024743A1 (en) | 2012-02-02 |
| CN103349643A (zh) | 2013-10-16 |
| EA023502B1 (ru) | 2016-06-30 |
| CA2751633A1 (en) | 2010-08-12 |
| CL2011001875A1 (es) | 2012-07-13 |
| ZA201105662B (en) | 2012-10-31 |
| KR20110120304A (ko) | 2011-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1005433A2 (pt) | preparações farmacêuticas transdérmicas | |
| HUE062860T2 (hu) | Magas koncentrációjú gyógyszerészeti készítmények | |
| IL245328A0 (en) | Pharmaceutical composition | |
| SMT201700008B (it) | Composizione farmaceutica | |
| BR112012011902A2 (pt) | cápsula farmacêutica | |
| SMT201400069B (it) | Formulazione farmaceutica | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| HRP20160579T1 (hr) | Spoj indola i njegova farmaceutska upotreba | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| IL226307A0 (en) | Compounds and methods for treating pain | |
| HRP20150926T1 (xx) | Pripravci u krutom stanju | |
| PT2696848T (pt) | Nanossuspensões de fármaco liofilizadas | |
| HUE040119T2 (hu) | Orálisan alkalmazott kortikoszteroid készítmények | |
| SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
| IT1394860B1 (it) | Composti farmaceutici | |
| IL230838A0 (en) | Pharmaceutical compositions | |
| EP2425827A4 (en) | TRANSDERMALES PREPARATION | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| GT201200303A (es) | Formulaciones farmacéuticas | |
| EE201300005A (et) | Ravimkoostis | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| HUE047767T2 (hu) | Macitentánt tartalmazó terápiás készítmények | |
| BRPI0922653A2 (pt) | preparação farmacêutica | |
| EP2399607A4 (en) | TRANSDERMALE PREPARATION | |
| BR112013008074A2 (pt) | combinações farmacêuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |